Solid Biosciences Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Solid Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $17.38. The average 1-year stock price forecast is 140.72% higher than the current stock price, while the lowest is $11 (+52.35%) and the highest is $26 (+260.11%).

Price Target: $17.38 (+140.72%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$11	$17.38	$16	$26
Change	+52.35%	+140.72%	+121.61%	+260.11%

Analyst Ratings

The average analyst rating for Solid Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	9	9	10	10	10	10
Buy	4	4	4	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	14	14	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yigal Nochomovitz Citi	Citi	Buy Reiterates $14	Buy	Reiterates	$14	+93.91%	Jun 5, 2026
Arthur He CFA H.C. Wainwright	H.C. Wainwright	Buy Reiterates $20 → $25	Buy	Reiterates	$20 → $25	+246.26%	Jun 3, 2026
Anupam Rama J.P. Morgan	J.P. Morgan	Buy Maintains $12 → $11	Buy	Maintains	$12 → $11	+52.35%	May 23, 2026
Laura Chico Wedbush	Wedbush	Buy Maintains $16	Buy	Maintains	$16	+121.61%	May 18, 2026
Geulah Livshits Chardan Capital	Chardan Capital	Buy Reiterates $15	Buy	Reiterates	$15	+107.76%	May 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

11.08M

EPS This Year

-1.96

from -1.99

EPS Next Year

-1.96

from -1.96

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	13.62M	8.09M	-	-	-	-
Gross Profit	-45.12M	-70.33M	-	-	-	-
Gross Margin	-331.27%	-868.87%	-	-	-	85.00%
Operating Income	-72.25M	-94.40M	-104.32M	-129.73M	-179.21M	-237.27M
Net Income	-72.19M	-85.98M	-96.02M	-124.70M	-174.33M	-231.56M
EPS	-	-	-	-	-1.99	-1.96
Free Cash Flow	-40.95M	-45.32M	-64.71M	-56.21M	-99.70M	-214.29M
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-1.67
Avg	-1.96
Low	-2.51

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-